Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. 1995

E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
Institute of Cancer Research and Molecular Biology, University of Trondheim, University Medical Centre, Norway.

Lipopolysaccharide (LPS), a part of the Gram-negative bacteria cell wall, is a potent inducer of tumor necrosis factor (TNF). TNF is an important mediator in Gram-negative infections such as meningococcal septic shock, but its harmful action can be prevented by the natural occurring soluble (s) TNF receptors (sTNFR) sp55 and sp75. In this study, the effect of LPS on release of sTNFR was investigated. First, we found a selective increase in human whole-blood sp75 TNFR levels following LPS stimulation, accompanied by no increase in sp55. Separating the different blood cell populations, mononuclear cells (PBMC) selectively released sp75 upon LPS stimulation, while LPS induced a minor increase in sp75 release from polymorphonuclear granulocytes. Interestingly, in co-cultures of PBMC and granulocytes, the release of LPS-induced sp75 TNFR was enhanced. Second, adherent monocytes were also found to selectively release sp75 TNFR upon LPS stimulation, where Neisseria meningitidis LPS was found to be 100-1000 times more potent in inducing sp75 release than Escherichia coli LPS. Using flow cytometry, the monocyte membrane distribution of both TNFR were found to be increased after LPS stimulation. Third, human umbilical vein endothelial cells selectively released sp55 TNFR after stimulation with LPS. We conclude that mononuclear and endothelial cells might be the main sources of soluble p75 and p55 TNFR, respectively, observed in Gram-negative sepsis, although these receptors are released in vivo more rapidly than they are in vitro.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D047889 Receptors, Tumor Necrosis Factor, Type II A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS. Antigens, CD120b,CD120b Antigens,Receptors, Tumor Necrosis Factor, Member 1B,Tumor Necrosis Factor Receptor Superfamily, Member 1B,Tumor Necrosis Factor Receptor Type II,CD 120b Antigen,CD120b Antigen,TNF-R2,TNF-R75,TNF-RII,TNF-sR75,TNFR p75,TNFR p80,TNFR2,TNFRSF1B Receptor,Tumor Necrosis Factor Receptor 2,Tumor Necrosis Factor Receptor 75,Tumor Necrosis Factor Receptor Type 2,120b Antigen, CD,Antigen, CD 120b,Antigen, CD120b,Receptor, TNFRSF1B
D018124 Receptors, Tumor Necrosis Factor Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells. Cachectin Receptors,TNF Receptors,Tumor Necrosis Factor Receptors,Receptors, Cachectin,Receptors, TNF,TNF Receptor,Tumor Necrosis Factor Receptor,Receptor, TNF

Related Publications

E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
March 1998, Biochemical and biophysical research communications,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
January 1997, Archivum immunologiae et therapiae experimentalis,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
April 1990, Biochemical and biophysical research communications,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
November 1991, European journal of immunology,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
December 1987, Infection and immunity,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
April 2009, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
November 1999, Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
October 1997, Brain research,
E Lien, and N B Liabakk, and A C Johnsen, and U Nonstad, and A Sundan, and T Espevik
May 1998, Infection and immunity,
Copied contents to your clipboard!